EmbryoNet-AI
EmbryoNet-AI38
About
What does EmbryoNet-AI do?
EmbryoNet-AI is an ERC-funded research-to-commercialization project developing deep learning models for automated embryonic and organoid phenotyping. The platform enables faster, more accurate assessment of compound effects in drug discovery and toxicology studies, reducing dependence on animal models. The project is building a user-friendly web interface and collaborating with pharma partners to commercialize the technology.
What is EmbryoNet-AI's revenue?
StartupHub estimates EmbryoNet-AI's annual revenue at $8K (range $6K to $62K, 32% confidence), based on comparable companies in the sector.
What is EmbryoNet-AI's valuation?
StartupHub estimates EmbryoNet-AI's effective valuation at $564K (range $375K to $900K, 23% confidence), based on comparable companies in the sector.
How much funding has EmbryoNet-AI raised?
EmbryoNet-AI has raised a total of $150K in funding. The most recent round on record is Grant.
Where is EmbryoNet-AI headquartered?
EmbryoNet-AI is headquartered in Lisbon, Portugal.
When was EmbryoNet-AI founded?
EmbryoNet-AI was founded in 2025.
What industry does EmbryoNet-AI operate in?
EmbryoNet-AI operates in Biotech, Drug Discovery, AI, Medical Imaging, Toxicology, Embryology.
AI precision medicine company transforming cancer diagnostics and patient outcomes through cutting-edge foundation models and multi-modal data.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 5 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.